2022年第25届澳大利亚更年期学会年会

2022年第25届澳大利亚更年期学会年会(AMS2022)将于2022年9月2-4日在新西兰皇后镇举行。

澳大利亚更年期学会(AMS)由对中年和更年期妇女健康感兴趣的医师和医疗保健专业人士组成。AMS的宗旨是提高对更年期的认识，改善绝经期间和之后妇女的生活质量；促进对中年妇女健康的讨论、研究和理解；鼓励和支持对中年妇女健康各个方面的研究；向卫生专业人员和公众宣传播质量信息；鼓励将该信息和知识应用于临床最佳实践。AMS每年在澳大利亚或新西兰举行年度科学大会。

AMS 2022 – 25th Annual Australasian Menopause Society Congress
Date: 2-4 September 2022
Venue: The Millennium, Queenstown, New Zealand

On behalf of the AMS we are pleased to announce the 2022 AMS Congress will be delivered as a hybrid event with both onsite and online attendance options. We hope as many of you as possible can join us in Queenstown, New Zealand!

The congress will be held 2-4 September 2022 at The Millennium Queenstown, or online, as we reflect on our experiences and knowledge on midlife and menopause.

Whether you are participating in the Congress as an onsite or an online delegate, the 2022 congress will offer you a stimulating scientific program designed to inform while encouraging time for reflection.

Our national and international speakers will explore the latest research across a range of topics.

Our clinically focused and always popular Pre-Congress Menopause Essentials Update will also be run again.

We hope as many of you as possible will be able to join us in Queenstown, New Zealand, but we are providing an online option to facilitate the participation of our colleagues who are unable to travel to New Zealand. All presentations, including those in the Update, will be streamed to online delegates, with presentations available to view by all attendees in the portal for 3 months following the Congress. Onsite and online delegates will be able to connect with each other via the Meeting Hub in the portal.

All sponsors and exhibitors will also have an online branding/resource presence to promote their products and services to online delegates.

For those of you who are able to travel, we look forward to welcoming you to the congress venue.

So join us, renew old acquaintances and make new connections in Queenstown or online in September 2022!

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。